BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18225582)

  • 1. The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.
    Vairaktaris E; Serefoglou ZC; Yapijakis C; Vassiliou S; Nkenke E; Avgoustidis D; Vylliotis A; Stathopoulos P; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4121-5. PubMed ID: 18225582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
    Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
    Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
    Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer.
    Vairaktaris E; Yapijakis C; Nkenke E; Serefoglou ZC; Chatzitheofylaktou A; Vassiliou S; Derka S; Vylliotis A; Perrea D; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4027-30. PubMed ID: 18225566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene.
    Salomon O; Rosenberg N; Steinberg DM; Huna-Baron R; Moisseiev J; Dardik R; Goldan O; Kurtz S; Ifrah A; Seligsohn U
    Ophthalmology; 2004 Jan; 111(1):184-8. PubMed ID: 14711733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E
    Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease.
    Jilma-Stohlawetz P; Jilma B; Mannhalter C; Bencur P; Pabinger I; Vormittag R; Dunkler D; Panzer S
    Ann Hematol; 2007 Oct; 86(10):719-25. PubMed ID: 17634946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
    Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
    Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
    Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancer.
    Vairaktaris E; Serefoglou Z; Yapijakis C; Stathopoulos P; Vassiliou S; Derka S; Nkenke E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):3981-6. PubMed ID: 18225559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer.
    Vairaktaris E; Yapijakis C; Derka S; Vassiliou S; Serefoglou Z; Vylliotis A; Wiltfang J; Springer I; Nkenke E; Kessler P; Neukam FW
    Eur J Surg Oncol; 2006 May; 32(4):455-7. PubMed ID: 16513317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma.
    Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Spyridonidou S; Neukam FW; Schlegel KA; Patsouris E
    Anticancer Res; 2008; 28(1A):309-14. PubMed ID: 18383862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.
    Vairaktaris E; Yapijakis C; Serefoglou Z; Vylliotis A; Ries J; Nkenke E; Wiltfang J; Derka S; Vassiliou S; Springer I; Kessler P; Neukam FW
    Oral Oncol; 2006 Oct; 42(9):888-92. PubMed ID: 16730474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer.
    Vairaktaris E; Serefoglou ZC; Yapijakis C; Agapi C; Vassiliou S; Nkenke E; Antonis V; Sofia S; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(6B):4011-4. PubMed ID: 18225563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are factor V and prothrombin mutations associated with increased risk of oral cancer?
    Vairaktaris E; Yapijakis C; Wiltfang J; Ries J; Vylliotis A; Derka S; Vasiliou S; Neukam FW
    Anticancer Res; 2005; 25(3c):2561-5. PubMed ID: 16080493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
    Vairaktaris E; Serefoglou Z; Yapijakis C; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E
    Anticancer Res; 2007; 27(4B):2493-8. PubMed ID: 17695544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
    Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable number of tandem repeats polymorphism of platelet glycoprotein Ib alpha in Chinese people and CC genotype with aspirin sensitivity in patients with cerebral infarction.
    Jin YY; Yu GZ; Wang Y; Cui LY; Xin XM
    J Clin Pharm Ther; 2009 Apr; 34(2):239-43. PubMed ID: 19250145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.